In summary, 125I particles inhibit the progression of cervical cancer by up-regulating the HSF1/PU.1/SYK signaling pathway and enhancing the ROS/USP7/P53-mediated apoptotic response (Fig. 8). The gene discussed is TP53; the disease is cervical carcinoma.